A+ R A-

Transplant Therapy of WM

Please select from the following list of abstracts, representing the presentations given in Stockholm 2008 (IWWM-5) Session 7:

Fludarabine for Waldenström’s macroglobulinemia (WM) – A 10 year follow-up of Southwest Oncology Group (SWOG) directed Intergroup trial S9003. Bart Barlogie, Madhav Dhodapkar and John Crowley for SWOG; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR; Yale University, Brookhaven, CT; Cancer Research and Statistics, Seattle, WA.

Haematopoietuc stem cell transplantation for Waldenström’s macroglobulinemia (WM) patients. H. Kyriakou, on behalf of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation  (EBMT), London, UNITED KINGDOM.

Evidence for GVWM following mini-allo in WM. David G. Maloney and Larry D. Anderson, Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington, Seattle, WA, USA.

Stem cell transplantation for IgM amyloidosis and IgM multiple myeloma. Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Kumar S, Hayman, SR, Buadi F. Mayo Clinic, Rochester, Minnesota, USA.

Stockholm 2008 (IWWM-5)

The 5th International Workshop on WM (IWWM-5) was made possible through the kind and generous unrestricted grants or gifts from the following sponsors:

Peter and Helen Bing Fund for Waldenström's Macroglobulinemia


Karen Lee Sobol Foundation


Bailey family Foundation for Waldenström's Macroglobulinemia


Linda and Edward Nelson Fund for Waldenström's Macroglobulinemia